Selected research
Industry Research
Actonel (Risedronic Acid) Industry Research Report 2026
Market perspective
The global Actonel (Risedronic Acid) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Actonel (Risedronic Acid) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Actonel (Risedronic Acid) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Actonel (Risedronic Acid) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Actonel (Risedronic Acid) include Takeda, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries Ltd., Mylan, Warner Chilcott, Macleods Pharmaceuticals Ltd, Aurobindo Pharma, Apotex and Allergan plc (AbbVie Inc.), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Actonel (Risedronic Acid) market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Actonel (Risedronic Acid) Market by Company
Takeda
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries Ltd.
Mylan
Warner Chilcott
Macleods Pharmaceuticals Ltd
Aurobindo Pharma
Apotex
Allergan plc (AbbVie Inc.)
Actonel (Risedronic Acid) Segment by Type
5 mg
35 mg
75 mg
150 mg
Actonel (Risedronic Acid) Segment by Application
Paget's Disease of Bone
Osteoporosis
Others
Actonel (Risedronic Acid) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Actonel (Risedronic Acid) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Actonel (Risedronic Acid) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Actonel (Risedronic Acid).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Actonel (Risedronic Acid) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Actonel (Risedronic Acid) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Actonel (Risedronic Acid) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5 mg
- 35 mg
- 75 mg
- 150 mg
Applications
- Paget's Disease of Bone
- Osteoporosis
- Others
Companies covered
- Takeda
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries Ltd.
- Mylan
- Warner Chilcott
- Macleods Pharmaceuticals Ltd
- Aurobindo Pharma
- Apotex
- Allergan plc (AbbVie Inc.)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Actonel (Risedronic Acid) Market Size (2021-2032)
- 2.2.2 Global Actonel (Risedronic Acid) Sales (2021-2032)
- 2.2.3 Global Actonel (Risedronic Acid) Market Average Price (2021-2032)
- 2.3 Actonel (Risedronic Acid) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5 mg
- 2.3.3 35 mg
- 2.3.4 75 mg
- 2.3.5 150 mg
- 2.4 Actonel (Risedronic Acid) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Paget's Disease of Bone
- 2.4.3 Osteoporosis
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Actonel (Risedronic Acid) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Actonel (Risedronic Acid) Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Actonel (Risedronic Acid) Revenue of Manufacturers (2021-2026)
- 3.4 Global Actonel (Risedronic Acid) Average Price by Manufacturers (2021-2026)
- 3.5 Global Actonel (Risedronic Acid) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Actonel (Risedronic Acid), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Actonel (Risedronic Acid), Product Type & Application
- 3.8 Global Manufacturers of Actonel (Risedronic Acid), Established Date
- 3.9 Global Actonel (Risedronic Acid) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Actonel (Risedronic Acid) Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 Teva Pharmaceutical Industries
- 4.2.1 Teva Pharmaceutical Industries Company Information
- 4.2.2 Teva Pharmaceutical Industries Business Overview
- 4.2.3 Teva Pharmaceutical Industries Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharmaceutical Industries Actonel (Risedronic Acid) Product Portfolio
- 4.2.5 Teva Pharmaceutical Industries Recent Developments
- 4.3 Sun Pharmaceutical Industries Ltd.
- 4.3.1 Sun Pharmaceutical Industries Ltd. Company Information
- 4.3.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 4.3.3 Sun Pharmaceutical Industries Ltd. Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sun Pharmaceutical Industries Ltd. Actonel (Risedronic Acid) Product Portfolio
- 4.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Actonel (Risedronic Acid) Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Warner Chilcott
- 4.5.1 Warner Chilcott Company Information
- 4.5.2 Warner Chilcott Business Overview
- 4.5.3 Warner Chilcott Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Warner Chilcott Actonel (Risedronic Acid) Product Portfolio
- 4.5.5 Warner Chilcott Recent Developments
- 4.6 Macleods Pharmaceuticals Ltd
- 4.6.1 Macleods Pharmaceuticals Ltd Company Information
- 4.6.2 Macleods Pharmaceuticals Ltd Business Overview
- 4.6.3 Macleods Pharmaceuticals Ltd Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Macleods Pharmaceuticals Ltd Actonel (Risedronic Acid) Product Portfolio
- 4.6.5 Macleods Pharmaceuticals Ltd Recent Developments
- 4.7 Aurobindo Pharma
- 4.7.1 Aurobindo Pharma Company Information
- 4.7.2 Aurobindo Pharma Business Overview
- 4.7.3 Aurobindo Pharma Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Aurobindo Pharma Actonel (Risedronic Acid) Product Portfolio
- 4.7.5 Aurobindo Pharma Recent Developments
- 4.8 Apotex
- 4.8.1 Apotex Company Information
- 4.8.2 Apotex Business Overview
- 4.8.3 Apotex Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Apotex Actonel (Risedronic Acid) Product Portfolio
- 4.8.5 Apotex Recent Developments
- 4.9 Allergan plc (AbbVie Inc.)
- 4.9.1 Allergan plc (AbbVie Inc.) Company Information
- 4.9.2 Allergan plc (AbbVie Inc.) Business Overview
- 4.9.3 Allergan plc (AbbVie Inc.) Actonel (Risedronic Acid) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Allergan plc (AbbVie Inc.) Actonel (Risedronic Acid) Product Portfolio
- 4.9.5 Allergan plc (AbbVie Inc.) Recent Developments
5 Global Actonel (Risedronic Acid) Market Scenario by Region
- 5.1 Global Actonel (Risedronic Acid) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Actonel (Risedronic Acid) Sales by Region: 2021-2032
- 5.2.1 Global Actonel (Risedronic Acid) Sales by Region: 2021-2026
- 5.2.2 Global Actonel (Risedronic Acid) Sales by Region: 2027-2032
- 5.3 Global Actonel (Risedronic Acid) Revenue by Region: 2021-2032
- 5.3.1 Global Actonel (Risedronic Acid) Revenue by Region: 2021-2026
- 5.3.2 Global Actonel (Risedronic Acid) Revenue by Region: 2027-2032
- 5.4 North America Actonel (Risedronic Acid) Market Facts & Figures by Country
- 5.4.1 North America Actonel (Risedronic Acid) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Actonel (Risedronic Acid) Sales by Country (2021-2032)
- 5.4.3 North America Actonel (Risedronic Acid) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Actonel (Risedronic Acid) Market Facts & Figures by Country
- 5.5.1 Europe Actonel (Risedronic Acid) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Actonel (Risedronic Acid) Sales by Country (2021-2032)
- 5.5.3 Europe Actonel (Risedronic Acid) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Actonel (Risedronic Acid) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Actonel (Risedronic Acid) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Actonel (Risedronic Acid) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Actonel (Risedronic Acid) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Actonel (Risedronic Acid) Market Facts & Figures by Country
- 5.7.1 South America Actonel (Risedronic Acid) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Actonel (Risedronic Acid) Sales by Country (2021-2032)
- 5.7.3 South America Actonel (Risedronic Acid) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Actonel (Risedronic Acid) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Actonel (Risedronic Acid) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Actonel (Risedronic Acid) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Actonel (Risedronic Acid) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Actonel (Risedronic Acid) Sales by Type (2021-2032)
- 6.1.1 Global Actonel (Risedronic Acid) Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Actonel (Risedronic Acid) Sales Market Share by Type (2021-2032)
- 6.2 Global Actonel (Risedronic Acid) Revenue by Type (2021-2032)
- 6.2.1 Global Actonel (Risedronic Acid) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Actonel (Risedronic Acid) Revenue Market Share by Type (2021-2032)
- 6.3 Global Actonel (Risedronic Acid) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Actonel (Risedronic Acid) Sales by Application (2021-2032)
- 7.1.1 Global Actonel (Risedronic Acid) Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Actonel (Risedronic Acid) Sales Market Share by Application (2021-2032)
- 7.2 Global Actonel (Risedronic Acid) Revenue by Application (2021-2032)
- 7.2.1 Global Actonel (Risedronic Acid) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Actonel (Risedronic Acid) Revenue Market Share by Application (2021-2032)
- 7.3 Global Actonel (Risedronic Acid) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Actonel (Risedronic Acid) Value Chain Analysis
- 8.1.1 Actonel (Risedronic Acid) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Actonel (Risedronic Acid) Production Mode & Process
- 8.2 Actonel (Risedronic Acid) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Actonel (Risedronic Acid) Distributors
- 8.2.3 Actonel (Risedronic Acid) Customers
9 Global Actonel (Risedronic Acid) Analyzing Market Dynamics
- 9.1 Actonel (Risedronic Acid) Industry Trends
- 9.2 Actonel (Risedronic Acid) Industry Drivers
- 9.3 Actonel (Risedronic Acid) Industry Opportunities and Challenges
- 9.4 Actonel (Risedronic Acid) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst